The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
January 3rd 2025
Higher levels of small-particle HDL were linked with greater gray matter volume and higher cognitive capacity among middle-aged adults.
DAPA-HF Reveals Reduced Death, Hospitalizations from HF with Dapagliflozin
September 1st 2019Results of the DAPA-HF study — presented at the ESC Congress 2019, reveal use of dapagliflozin reduce hospitalizations from heart failure and deaths from cardiovascular causes in patients with heart failure with reduced ejection fraction.
PARAGON-HF Reveals No Significant Benefit of Sacubitril-Valsartan for HF
September 1st 2019Results of the PARAGON HF study, which were presented at ESC Congress 2019, reveal no significant benefit of sacubitril-valsartan compared to valsartan for heart failure with preserved ejection fraction in more than 4,500 patients.